|
03 Sep 2025 |
Hindustan Unilever
|
Consensus Share Price Target
|
2677.00 |
2704.39 |
- |
1.02 |
buy
|
|
|
|
|
26 Jun 2023
|
Hindustan Unilever
|
ICICI Securities Limited
|
2677.00
|
2800.00
|
2652.10
(0.94%)
|
|
Accumulate
|
|
|
Sanjiv Mehta as MD & CEO of HUL over 2013-2023 delivered impressive CAGR of 20% in TSR and 13% in EBITDA. HUL stock's P/E rerated to ~50x from ~25-30x (highest rerating in sector).
|
|
26 Jun 2023
|
Hindustan Unilever
|
ICICI Securities Limited
|
2677.00
|
2800.00
|
2652.10
(0.94%)
|
|
Accumulate
|
|
|
As we welcome Mr. Rohit Jawa as the new MD & CEO of HUL, we believe, it is important to reflect on HUL CEOs' performance history over the past 30+ years and outline our expectations from Rohit. History may not repeat itself, but it does often rhymes and provide valuable insights.
|
|
12 Jun 2023
|
Hindustan Unilever
|
Motilal Oswal
|
2677.00
|
3100.00
|
2643.45
(1.27%)
|
|
Buy
|
|
|
|
|
05 Jun 2023
|
Hindustan Unilever
|
BOB Capital Markets Ltd.
|
2677.00
|
3069.00
|
2695.80
(-0.70%)
|
|
Buy
|
|
|
Growth momentum continues with 16% YoY topline growth in FY23 and market share gains in >75% of the portfolio
|
|
02 May 2023
|
Hindustan Unilever
|
SMC online
|
2677.00
|
|
2451.70
(9.19%)
|
|
Results Update
|
|
|
|
|
28 Apr 2023
|
Hindustan Unilever
|
ICICI Direct
|
2677.00
|
2780.00
|
2457.30
(8.94%)
|
|
Hold
|
|
|
|
|
28 Apr 2023
|
Hindustan Unilever
|
Axis Direct
|
2677.00
|
2800.00
|
2457.30
(8.94%)
|
|
Buy
|
|
|
Recommendation With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
27 Apr 2023
|
Hindustan Unilever
|
BOB Capital Markets Ltd.
|
2677.00
|
3069.00
|
2468.95
(8.43%)
|
|
Buy
|
|
|
Underlying pricing growth tapered down in Q4 due to softening input cost; volume growth at 4% YoY
|
|
27 Apr 2023
|
Hindustan Unilever
|
Prabhudas Lilladhar
|
2677.00
|
2785.00
|
2468.95
(8.43%)
|
|
Accumulate
|
|
|
|
|
27 Apr 2023
|
Hindustan Unilever
|
ICICI Securities Limited
|
2677.00
|
2750.00
|
2468.95
(8.43%)
|
Target met |
Accumulate
|
|
|
HUL’s 4Q performance of 11% YoY revenue growth and 4% volume growth (UVG) were below expectations as the consensus assumption of (immediate) volume growth trajectory improvement with passing on benefits of raw material correction (pricing growth has come down from ~11% to ~7% sequentially) to consumers has not come true.
|